Front-line treatment of advanced non-small cell lung cancer with docetaxel and Gemcitabine: A multicenter phase II trial

被引：0
|
作者：
Georgoulias, V [1 ]
Kourousis, C [1 ]
Kakolyris, S [1 ]
Dimopoulos, MA [1 ]
Papadakis, E [1 ]
Apostolopulou, F [1 ]
Agelidou, A [1 ]
Tzianni, V [1 ]
Sarra, E [1 ]
Vardakis, N [1 ]
机构：
[1] Univ Gen Hosp Heraklion, Dept Med Oncol, Greek Cooperat Grp Lung Canc, Heraklion 71110, Crete, Greece
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
453
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [31] Ifosfamide and gemcitabine: A phase II trial in advanced inoperable non-small cell lung cancer
    Gatzemeier, U
    Manegold, C
    Eberhard, W
    Wilke, HJ
    Chomy, F
    Chomy, P
    Khayat, D
    Blatter, J
    Seeber, S
    Drings, P
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 15 - 18
  • [32] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [33] Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer.
    Treat, J
    McCleod, M
    Mintzer, D
    Christiansen, N
    Bonomi, P
    Monberg, M
    Taylor, L
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 648S - 648S
  • [34] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [35] Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial
    G. P. Stathopoulos
    C. Katis
    D. Tsavdaridis
    J. Dimitroulis
    D. Karaindros
    J. Stathopoulos
    E. Dimou
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 555 - 560
  • [36] Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial
    Stathopoulos, G. P.
    Katis, C.
    Tsavdaridis, D.
    Dimitroulis, J.
    Karaindros, D.
    Stathopoulos, J.
    Dimou, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 555 - 560
  • [37] A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
    Pallis, AG
    Agelidou, A
    Papakotoulas, P
    Tsaroucha, A
    Agelidou, M
    Agelaki, S
    Androulakis, N
    Vamvakas, L
    Gerogianni, A
    Kotsakis, A
    Kentepozidis, N
    Georgoulias, V
    LUNG CANCER, 2006, 52 (02) : 165 - 171
  • [38] Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: Phase II trial
    Serke, M
    Schoenfeld, N
    Loddenkemper, R
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1211 - 1216
  • [39] Docetaxel and Oxaliplatin as First-Line Therapy for Advanced Non-Small Cell Lung Cancer: A Phase II Trial
    Radhakrishnan, A.
    Bitran, J. D.
    Milton, D. T.
    Tolzien, K.
    Hallmeyer, S.
    Nabhan, C.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (04) : 439 - 444
  • [40] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
12345